Response of freshly isolated follicular lymphoma cells to rituximab

Project Information

CARTRON GUILLAUME

Grant agreement ID: QLK2-CT-2002-51219

Start date

End date

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 65 756,00

EU contribution € 65 756,00

Coordinated by

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH
Italy

Objective

Analysis of gene patterns induced by rituximab in freshly isolated follicular lymphoma cells and of their in-vitro susceptibility to rituximab combined with fludarabine and cyclophophamide

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH

• EU contribution: No data
• Address: Via Eritrea 62 ; 20157 MILANO ; Italy
• Total cost: No data